These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1181591)

  • 1. [Tablets. XV. Influence of Precirol on the in vitro liberation of sodium salicylate. The process of coating the grains].
    Terrier JL; Paris J; Duchène D; Puisieux F
    Pharm Acta Helv; 1975; 50(7-8):226-31. PubMed ID: 1181591
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tablets. XIV. Influence of Precirol on the in vitro liberation of sodium salicylate. The process of granulation and inclusion].
    Terrier JL; Touré P; Meimoun J; Duchène D; Puisieux F
    Pharm Acta Helv; 1975; 50(7-8):219-25. PubMed ID: 1181590
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tablets. XVII. Effect of pressure on the liberation in vitro of sodium salicylate from prolonged-action tablets].
    Terrier JL; Cruaud-Mangenot O; Duchène D; Puisieux F
    Pharm Acta Helv; 1976; 51(5):144-52. PubMed ID: 967910
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of various sodium salts on the integration of starch containing tablets].
    Proshunina DV
    Farm Zh; 1971; 26(2):48-52. PubMed ID: 5152487
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coating tablets with a protective film].
    Shmar'ian MI; Shcherbakova OV
    Farmatsiia; 1976; 25(1):67-70. PubMed ID: 1254007
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spray film coating of spherical microgranules with non-aqueous varnish film-formers].
    Voigt R; Wunsch G
    Pharmazie; 1985 Nov; 40(11):772-6. PubMed ID: 4095127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the production and control of tablets. XVII. Native starches as pharmaceutic aids].
    Chalabala M; Heliová M
    Cesk Farm; 1976 May; 25(3-4):125-8. PubMed ID: 947558
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
    Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factorial pilot project for the optimization of technological parameters of film coating in the manufacturing process. I. Laboratory manufacture of enteric-coated tablets and their analysis].
    Dévay A; Rácz I
    Acta Pharm Hung; 1986 Sep; 56(5):227-31. PubMed ID: 3799195
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gastro-resistant cellulose acetophthalate coatings. I. Correlation between film thickness and in vitro resistance of the coating].
    Chaumeil JC; Piton Y
    Ann Pharm Fr; 1973 May; 31(5):375-84. PubMed ID: 4794074
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on tablets. XV. Holocellulose and technical cellulose as substances promoting the disintegration of tablets].
    Malý J; Chalabala M; Heliová M; Necesaný V
    Cesk Farm; 1967 May; 16(4):194-7. PubMed ID: 6080493
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of various factors on the velocity of drug release from depot tablets. 2. Isoniazid-depot tablets].
    Naplatanova D; Tomassini L
    Pharmazie; 1974 May; 29(5):321-3. PubMed ID: 4848951
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 5th Part: Bioavailability of Riboflavin enteric coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(4):341-54. PubMed ID: 978382
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coatings. II. Comparison of some filmogenic products and plastifiers for coating in a turbine].
    Laguna O; Luong TT; Lefort des Ylouses D
    Ann Pharm Fr; 1974 Dec; 32(12):641-55. PubMed ID: 4466421
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material.
    Lai X; Sun C; Tian H; Zhao W; Gao L
    Int J Pharm; 2008 Mar; 352(1-2):66-73. PubMed ID: 18054184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Description of the process of in vitro liberation of matrix tablets].
    Appelt B; Kala H
    Pharmazie; 1986 Nov; 41(11):784-6. PubMed ID: 3562511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the production and control of tablets. XVIII. Modified starches as pharmaceutic aids].
    Chalabala M; Heliová M
    Cesk Farm; 1977 Apr; 26(3):108-11. PubMed ID: 872228
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of an optimal enteric-soluble film-forming composite based on acetylphthalylcellulose for coating tablets in a fluidized bed].
    Groshovyĭ TA; Ustianich EP; Pozdniakova VT; Borisenko IuB
    Farm Zh; 1975; (2):47-51. PubMed ID: 1140359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.